𝔖 Bobbio Scriptorium
✦   LIBER   ✦

S4.13 Epidermal growth factor induces glycolipid sulfotransferase activity in human renal cell carcinoma cells

✍ Scribed by A. Makita; T. Kobayashi; K. Honke; T. Miyazaki


Publisher
Springer US
Year
1993
Tongue
English
Weight
246 KB
Volume
10
Category
Article
ISSN
1573-4986

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Epidermal growth factor elevates the act
✍ Takahiko Kobayashi; Koichi Honke; Shinsei Gasa; Naoyuki Kato; Akira Makita; Tamo πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 French βš– 602 KB

Accumulation of sulfoglycolipids associated with markedly elevated levels of glycolipid-sulfotransferase activity was previously demonstrated in human renal-cell-carcinoma cells. To elucidate the regulatory mechanisms of sulfoglycolipid metabolism in renal-cell carcinoma, effects of various growth f

Epidermal growth factor induces terminal
✍ Raymond L. Konger; Thomas C. K. Chan πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 836 KB

Previous studies have reported that the proliferation of A431 cells, a human squamous cell carcinoma cell line, was stimulated by picomolar epidermal growth factor (EGF) but inhibited by nanomolar EGF. This biphasic dose-response phenomenon is not observed in normal human epithelial cells where nano

Amplification and overexpression of the
✍ Jiro Ishikawa; Sakan Maeda; Kei-Ichi Umezu; Taketoshi Sugiyama; Sadao Kamidono πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 French βš– 512 KB

We examined 22 cases of renal-cell carcinoma (RCC) for structural alterations of the epidermal growth factor receptor (ECFR) gene and found gene amplification in one case of high-stag+high-grade RCC. Dot blot analysis of the total RNA from tumorous and normal kidney tissues revealed overexpression o

Inhibition of epidermal growth factor-in
✍ Toru Shiratsuchi; Hiroaki Ishibashi; Kanemitsu Shirasuna πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 241 KB πŸ‘ 1 views

## Abstract Invasive squamous cell carcinoma (SCC) cells degrade extracellular matrix (ECM) via an extracellular protease cascade that includes urokinase‐type plasminogen activator (uPA), plasmin, and the metalloprotease (MMP) family of collagenases. In this study, treatment of oral SCC cells with